Chilwa Announces Closing of US$3.5 Million Offering

First Hawaiian to Report Third Quarter 2026 Financial Results on October 23, 2026

PMET Resources Files Amended Version of its NI 43-101 Technical Report on the CV5 Lithium-Only Feasibility Study Previously Published in...

PMET Resources Files Amended Version of its NI 43-101 Technical Report on the CV5 Lithium-Only Feasibility Study Previously Published in...

Phillips & Associates Sets Date for 2027 National Plaintiffs' Summit on Sexual Harassment & Employment Discrimination

Canadian Investment Regulatory Organization Trade Resumption - NILI

Minister MacDonald concludes tour in New Brunswick and Prince Edward Island

Graham Carr Appointed as Chair of the Board of Trustees of the Canadian Museum of History and the Canadian War Museum

Minister McKnight tours Westridge Marine Terminal, showcasing Canada's ability to build major energy infrastructure responsibly

iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026

Hale Hōkūala Kauaʻi Debuts as Curio Collection by Hilton's First Hawaiʻi Resort

Moon Valley Nurseries Surpasses 50 Locations Nationwide, Launches Tree Care Division

AtlasClear Holdings Announces Long-Term Stock Option Awards to Support Leadership Retention and Shareholder Alignment

Elauwit Investor News: If You Have Suffered Losses in Elauwit Connection, Inc. (NASDAQ: ELWT), You Are Encouraged to Contact The Rosen Law...

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Celsius Holdings, Inc. Investors to Secure Counsel Before Important Deadline in...

MAYORAL CANDIDATE GRAHAM ALEXANDER FILES LANDMARK $10 BILLION LAWSUIT AGAINST DNV, PROVINCE, AND FEDERAL GOVERNMENTS TO UNSEAL NSWTP SECRECY...

Beverly Hills Bed Marks 20 Years of Selling Adjustable Beds and Specialty Mattresses Online

The Quinism Foundation to Speak at Ottawa Mefloquine Conference Saturday October 3

ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Qfin Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities...

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)